Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Affiliations

• ¹ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
• ² Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.
• ³ Department of Mathematics, University of Ioannina, Ioannina, Greece.
• ⁴ MLL Munich Leukemia Laboratory, Munich, Germany.
• ⁵ Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
• ⁶ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
• ⁷ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
• ⁸ Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ⁹ Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
• ¹⁰ Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
• ¹¹ Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.
• ¹² Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
• ¹³ Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
• ¹⁴ Faculty of Medicine, Masaryk University, Brno, Czech Republic.
• ¹⁵ Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
• ¹⁶ Hospital Clínic of Barcelona, Barcelona, Spain.
• ¹⁷ Universitat de Barcelona, Barcelona, Spain.
• ¹⁸ Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.
• ¹⁹ Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.
• ²⁰ Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
• ²¹ Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
• ²² Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
• ²³ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
• ²⁴ Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK.
• ²⁵ All India Institute of Medical Sciences (AIIMS), New Delhi, India.
• ²⁶ Hospital Universitario 12 Octubre, Madrid, Spain.
• ²⁷ Spanish National Cancer Research (CNIO), Madrid, Spain.
• ²⁸ Haematology Department, Beaumont Hospital, Dublin, Ireland.
• ²⁹ Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
• ³⁰ IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
• ³¹ HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
• ³² Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
• ³³ Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
• ³⁴ Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
• ³⁵ Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
• ³⁶ Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
• ³⁷ Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France.
• ³⁸ Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France.
• ³⁹ Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland.
• ⁴⁰ Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain.
• ⁴¹ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.
• ⁴² Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.